Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Overuse of Neo-adjuvant Chemotherapy for Primary Breast Cancer
Nikita Wadhwani,
Ismail Jatoi
Mays Cancer Center
Division of Surgical Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Overuse of Neo-adjuvant Chemotherapy for Primary Breast Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Neoadjuvant Chemotherapy
100%
Patient
87%
Neoplasm
62%
Breast Cancer
50%
Quadrantectomy
25%
Therapeutic Procedure
25%
Overall Survival
12%
Recurrent Disease
12%
Adjuvant Chemotherapy
12%
Primary Tumor
12%
Systemic Therapy
12%
Capecitabine
12%
Enalapril Maleate
12%
Locally Advanced Breast Cancer
12%
Micrometastasis
12%
Inflammatory Breast Cancer
12%
Clinician
12%
Breast
12%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
62%
Breast Cancer
50%
Chemotherapy
25%
Overall Survival
12%
Recurrent Disease
12%
Primary Tumor
12%
Enalapril Maleate
12%
Capecitabine
12%
Inflammatory Breast Cancer
12%
Micrometastasis
12%
Death
12%